The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end-stage renal disease
Abstract
Purpose:
To determine whether somatic or cognitive depressive symptoms affect hospitalization and death in patients with end-stage renal disease.
Design and Method:
In an observational retrospective design, the patients (n = 190) completed the Beck Depression Inventory-II at baseline and were followed for 5 years to collect data all-cause mortality and hospitalization.
Findings:
High somatic (53.7%, n = 102) and cognitive (52.1%, n = 99) depressive symptoms scores significantly associated with mortality (38% vs. 19%; hazard ratio [HR] = 2; 95% CI, 1.1–3.7; p = 0.02) and hospitalization (62.5% vs. 49.4%; HR = 1.6; 95% CI, 1.0–2.6; p = 0.03), respectively.
Practice Implications:
In the context of diagnosing and intervening, awareness of depressive symptoms dimensionality is crucial.
RAS ID
35625
Document Type
Journal Article
Date of Publication
1-1-2022
Volume
58
Issue
1
Funding Information
The Deanship of Scientific Research - The University of Jordan
PubMed ID
33861469
School
School of Nursing and Midwifery
Copyright
subscription content
Publisher
Wiley
Comments
Khalil, A. A., Darawad, M. W., Abed, M. A., Hamdan‐Mansour, A., Arabiat, D. H., Alnajar, M. K., & Saleh, Z. T. (2022). The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end‐stage renal disease. Perspectives in Psychiatric Care, 58(1), 297-303.
https://doi.org/10.1111/ppc.12786